Implementation of novel tools to facilitate fragment-based drug discovery by NMR:

Similar documents
Mnova Software Tools for Fragment-Based Drug Discovery

Using MnovaScreen to Process, Analyze and Report Ligand-Protein Binding Spectra for Fragment-based Lead Design

Fragment-based drug discovery

FRAGMENT SCREENING IN LEAD DISCOVERY BY WEAK AFFINITY CHROMATOGRAPHY (WAC )

Introduction to FBDD Fragment screening methods and library design

NMR Solutions for drug discovery

György M. Keserű H2020 FRAGNET Network Hungarian Academy of Sciences

Fragment Screening in Drug Discovery

Hit Finding and Optimization Using BLAZE & FORGE

Receptor Based Drug Design (1)

NMR methods in fragment screening: theory and a comparison with other biophysical techniques

Computational chemical biology to address non-traditional drug targets. John Karanicolas

In silico pharmacology for drug discovery

Retrieving hits through in silico screening and expert assessment M. N. Drwal a,b and R. Griffith a

Dr. Sander B. Nabuurs. Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre

Enamine Golden Fragment Library

Fragment-Based Drug Discovery (FBDD) Using the dispr Technique on Pioneer Systems with OneStep and NeXtStep Injection Methodologies

Development of Pharmacophore Model for Indeno[1,2-b]indoles as Human Protein Kinase CK2 Inhibitors and Database Mining

Using Phase for Pharmacophore Modelling. 5th European Life Science Bootcamp March, 2017

La RMN quantitative appliquée aux petites molécules

ImprovIng ADmE ScrEEnIng productivity In Drug DIScovEry

Application Note 12: Fully Automated Compound Screening and Verification Using Spinsolve and MestReNova

Structure-Based Drug Discovery An Overview

Mnova Software for Analyzing Reaction Monitoring NMR Spectra

MSc Drug Design. Module Structure: (15 credits each) Lectures and Tutorials Assessment: 50% coursework, 50% unseen examination.

Produktivitätswerkzeuge für die NMR

MD Simulation in Pose Refinement and Scoring Using AMBER Workflows

Knowledge instead of ignorance. More efficient drug design through the understanding of experimental uncertainty

Structure-based maximal affinity model predicts small-molecule druggability

Stephen McDonald, Mark D. Wrona, Jeff Goshawk Waters Corporation, Milford, MA, USA INTRODUCTION

Automated, High- Throughput Data Processing & Quantification: Illustrated by a series of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Application Note. Authors. Introduction. Lauren E. Frick and William A. LaMarr Agilent Technologies, Inc. Wakefield, MA, USA

COMBINATORIAL CHEMISTRY: CURRENT APPROACH

Supporting Information

MM-GBSA for Calculating Binding Affinity A rank-ordering study for the lead optimization of Fxa and COX-2 inhibitors

Virtual Screening: How Are We Doing?

Bioengineering & Bioinformatics Summer Institute, Dept. Computational Biology, University of Pittsburgh, PGH, PA

Quantification of free ligand conformational preferences by NMR and their relationship to the bioactive conformation

COMBINATORIAL CHEMISTRY IN A HISTORICAL PERSPECTIVE

Isothermal Titration Calorimetry in Drug Discovery. Geoff Holdgate Structure & Biophysics, Discovery Sciences, AstraZeneca October 2017

for XPS surface analysis

Docking. GBCB 5874: Problem Solving in GBCB

Biologically Relevant Molecular Comparisons. Mark Mackey

Supporting Information. Labeled Ligand Displacement: Extending NMR-based Screening of Protein Targets

Differential Scanning Fluorimetry: Detection of ligands and conditions that promote protein stability and crystallization

Practical QSAR and Library Design: Advanced tools for research teams

Supplementary Information. Overlap between folding and functional energy landscapes for. adenylate kinase conformational change

QSAR Modeling of ErbB1 Inhibitors Using Genetic Algorithm-Based Regression

FRAUNHOFER IME SCREENINGPORT

In Silico Investigation of Off-Target Effects

Six Biophysical Screening Methods Miss a Large Proportion of Crystallographically Discovered Fragment Hits: A Case Study

Supplementary Material

Mechanistic insight into inhibition of two-component system signaling

Important Aspects of Fragment Screening Collection Design

Joana Pereira Lamzin Group EMBL Hamburg, Germany. Small molecules How to identify and build them (with ARP/wARP)

Natural Products. Innovation with Integrity. High Performance NMR Solutions for Analysis NMR

Pulsar. Delivering NMR to your benchtop

Protein Structure Determination using NMR Spectroscopy. Cesar Trinidad

SEAMLESS INTEGRATION OF MASS DETECTION INTO THE UV CHROMATOGRAPHIC WORKFLOW

Applications of Fragment Based Approaches

We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors

CSD. CSD-Enterprise. Access the CSD and ALL CCDC application software

Targeting protein-protein interactions: A hot topic in drug discovery

Early Stages of Drug Discovery in the Pharmaceutical Industry

Medicinal Chemistry and Chemical Biology

est Drive K20 GPUs! Experience The Acceleration Run Computational Chemistry Codes on Tesla K20 GPU today

17. Biomolecular Interaction

Use of data mining and chemoinformatics in the identification and optimization of high-throughput screening hits for NTDs

Tools for Structure Elucidation

Bioorganic & Medicinal Chemistry

Design and Synthesis of the Comprehensive Fragment Library

Building innovative drug discovery alliances

CONFOCHECK. Innovation with Integrity. Infrared Protein Analysis FT-IR

Structural Bioinformatics (C3210) Molecular Docking

Advanced Medicinal Chemistry SLIDES B

Using AutoDock for Virtual Screening

Moscow Institute of Physics and Technology, Institutsky 9, Dolgoprudny , Russia 2

Identifying Interaction Hot Spots with SuperStar

EGASUS. 4D GCxGC TOFMS. Delivering the Right Results

NMR study of complexes between low molecular mass inhibitors and the West Nile virus NS2B-NS3 protease

Supporting Information

Multi-residue analysis of pesticides by GC-HRMS

NMR-Based Approaches for the Identification and Optimization of Inhibitors of Protein Protein Interactions

Intelligent NMR productivity tools

Integrated Cheminformatics to Guide Drug Discovery

A Tiered Screen Protocol for the Discovery of Structurally Diverse HIV Integrase Inhibitors

Simplified Approaches to Impurity Identification using Accurate Mass UPLC/MS

2D NMR: HMBC Assignments and Publishing NMR Data Using MNova

Medicinal Chemistry/ CHEM 458/658 Chapter 4- Computer-Aided Drug Design

QTOF-based proteomics and metabolomics for the agro-food chain.

Virtual Libraries and Virtual Screening in Drug Discovery Processes using KNIME

Metabolite Identification and Characterization by Mining Mass Spectrometry Data with SAS and Python

Unlocking the potential of your drug discovery programme

Automatic Generation of Extract ion Chromatogram for Mass Spectral Peaks with Specific Isotope Labeled Patterns

Supporting Information

Benchtop NMR Combined with GC/MS Confirms Identity of Forensic Case Sample

Chemogenomic: Approaches to Rational Drug Design. Jonas Skjødt Møller

Handling Human Interpreted Analytical Data. Workflows for Pharmaceutical R&D. Presented by Peter Russell

MassHunter TOF/QTOF Users Meeting

Agilent s new solution for obtaining routinely quantitative results from NMR measurements. Magnetic Resonance Systems

Transcription:

Implementation of novel tools to facilitate fragment-based drug discovery by NMR: Automated analysis of large sets of ligand-observed NMR binding data and 19 F methods Andreas Lingel Global Discovery Chemistry Novartis Institutes for BioMedical Research, Emeryville, CA November 5 th, 2013 PSDI 2013 Lucerne

Outline How to improve NMR-based, ligand-observed hit finding? Short introduction of workflow and main challenges Automated analysis of ligand-observed NMR binding data 19 F-based NMR applications 2 Improving NMR methods to support FBDD Andreas Lingel 2013/11/05 PSDI Lucerne

Several bottlenecks in target-based hit finding Need for tools to facilitate screening and characterization NMR SPR DSF Biochemical assays X-ray crystallography NMR Primary screening Confirmation Validation Single concentration Yes/no assessment Hit calling based on thresholds Dose response Specificity K D or IC 50 Rank ordering Structural information Localized binding site Specificity Analoging 3 Improving NMR methods to support FBDD Andreas Lingel 2013/11/05 PSDI Lucerne

Several bottlenecks in target-based hit finding Spectra are complex and manual analysis labor-intensive 1 H ligand-observed NMR experiments Primary screening Single concentration Yes/no assessment Hit calling based on thresholds T1rho wl STD Compounds in mixtures Spectra are complex and signals overlap Multiple experiments available (T1rho, WaterLOGSY, STD) Comparison to single compound spectra Time consuming manual analysis Automatic analysis of ligand-observed screening data 1 H [ppm] 4 Improving NMR methods to support FBDD Andreas Lingel 2013/11/05 PSDI Lucerne

Several bottlenecks in target-based hit finding Potential for robust, simplified and quantitative assays 1 H ligand-observed NMR experiments Single compound confirmation Protein-observed NMR experiments Chemical shift perturbations 15 N [ppm] T1rho Confirmation wl STD 1 H [ppm] Automated analysis & simple, quantitative NMR assays Dose response Specificity K D or IC 50 Rank ordering K D : 480±32 um 1 H [ppm] 0 um 50 um 100 um 200 um 500 um 800 um 1100 um 5 Improving NMR methods to support FBDD Andreas Lingel 2013/11/05 PSDI Lucerne

A novel software tool to process and analyze NMRbased binding data Features Workflow Imports and collates spectra Data processing Alignment and/or normalization Peak picking using Global Spectral Deconvolution (GSD) Matching of library peaks with the mixture (STD, T1ρ or WaterLOGSY) peaks and comparing of intensity changes Reporting of hits in a spreadsheet with quantitative data, interface for visual inspection 6 Improving NMR methods to support FBDD Andreas Lingel 2013/11/05 PSDI Lucerne

A novel software tool to process and analyze NMRbased binding data Results are easily accessible in table format, color coding for hits/no hits Reference spectra Reference spectra Visual inspection: Stacked spectra view within Mnova enables manual checking and modification of hit calling Mixture spectra without protein Mixture Spectra without Protein Mixture spectra with protein Mixture spectra with Protein 7 Improving NMR methods to support FBDD Andreas Lingel 2013/11/05 PSDI Lucerne

Performance against manually analyzed data Optimization of mixture analysis on-going T1rho and STD spectra of single compound experiments tested, hits from automated analysis compare well with manually analyzed results (> 85%) Currently testing of mixture data, large dataset from fragment library screen Primary hit calling (adding to total): 1 out of 3 experiments positive Example from a mixture analysis Manual analysis No. of hits T1rho 91 78 / 85% STD 180 100 / 55% WaterLOGSY 213 143 / 67% Total 202 159 / 79% No. and % found by Mnova screen 8 Improving NMR methods to support FBDD Andreas Lingel 2013/11/05 PSDI Lucerne

19 F-detected NMR provides many advantages Rapid and robust hit finding by 19 F NMR screening Compounds can be screened at very low concentration due to exquisite sensitivity of 19 F to binding and recent advancements in hardware Large chemical shift range allows screening of large mixtures Fast acquisition and very clean NMR spectra, enabling fast evaluation of screening data Fluorine is known to be involved in favorable interactions with proteins, e.g. carbonyl groups, Bissantz et. al (2010) J. Med. Chem., 53 Novel library design strategy based on local environment of fluorine concept, described by Vulpetti et. al (2009) J. Am. Chem. Soc., 131 Compounds screened in mixtures 10 um each Compounds only 19 F [ppm] 9 Improving NMR methods to support FBDD Andreas Lingel 2013/11/05 PSDI Lucerne

Simplification of data analysis Signal decrease can be easily quantified and analyzed automatically Addition of protein causes line broadening - binding Compounds only Protein added 19 F [ppm] 10 Improving NMR methods to support FBDD Andreas Lingel 2013/11/05 PSDI Lucerne

Different binding sites can be probed at screening stage with tool compounds Addition of tool compound restores the compound signal Compounds only Protein added Tool compound added 19 F [ppm] 11 Improving NMR methods to support FBDD Andreas Lingel 2013/11/05 PSDI Lucerne

Primary screening hit could be validated and progressed into potent series ~ 100 analogs of fragment hit were tested in thermal shift & biochemical assays (orthogonal validation) Positive hits were further validated by 2D NMR chemical shift perturbation experiments Alternative chemotype identified by 19 F-based screening Analoging, 2D NMR and docking provided basis for chemistry Binding mode of more potent analogs could be confirmed by crystallography New fragment-based chemotype currently progressed into nm inhibitors with favorable ligand efficiency parameters being retained 12 Improving NMR methods to support FBDD Andreas Lingel 2013/11/05 PSDI Lucerne

19 F-based NMR reporter assays Quantitative and structural information from a single measurement Requirements Reporter gets displaced by test compound Reporter binds to protein Reporter free in solution + + k on k off k on k off Fluorinated reporter compound Sufficient solubility to avoid assay artifacts Specific binding, affinity in ~10-200 um range Preferably crystal structure of bound reporter available 13 Improving NMR methods to support FBDD Andreas Lingel 2013/11/05 PSDI Lucerne

19 F-based NMR reporter assays Quantitative and structural information from a single measurement Reporter gets displaced by test compound + k on k off Example CF3 group Sol >600 um F=1.0 Reporter + protein + high affinity tool compound Reporter binds to protein + k on k off K D (SPR): 150 um IC 50 : 182 um F=0.18 Reporter + protein Reporter free in solution X-ray available Reporter in buffer F(I) rep ~ [ERep] Rep tot ~ K D (test compound) 19 F [ppm] Displacement of reporter by test compounds provides rank ordering/k D and confirms localized binding event 14 Improving NMR methods to support FBDD Andreas Lingel 2013/11/05 PSDI Lucerne

19 F-NMR reporter assay for diverse applications Quantitative and structural information from a single measurement Conditions 20 um reporter 1-5 um protein 50-500 um test compound < 5 min acquisition Applications No restriction on test compounds (size, properties) Data acquisition and analysis is simple and fast Suitable for HTS and FBS hit validation Quantification enables prioritization and application in compound optimization Protein + reporter + Compound 1 (IC 50 = 33.7 nm) + Fragment 1 (SPR K D = 60 μm) + Fragment 2 (SPR K D = 240 μm) + Fragment 3 (SPR K D = 190 μm) + Fragment 4 (SPR K D = 320 μm) 19 F [ppm] (individual spectra shifted for clarity) 15 Improving NMR methods to support FBDD Andreas Lingel 2013/11/05 PSDI Lucerne

Summary Novel software tool development towards automated analysis of ligand-observed NMR binding data Robustly identifies T1rho and STD hits single compound experiments in single compound experiments Performance on mixtures good and being improved WaterLOGSY module development started recently and being tested 19 F NMR provides fast and robust addition to compound screening repertoire Very sensitive and less prone to observing unspecific binding Libraries of 19 F-containing molecules enable primary screening (hit identification) 19 F-based NMR reporter assay provides simple way to generate quantitative binding data and confirms binding in desired pocket 16 Improving NMR methods to support FBDD Andreas Lingel 2013/11/05 PSDI Lucerne

Acknowledgements NIBR Emeryville, CA Andreas Frank Alexandra Frommlet Micah Steffek Dirk Bussiere NIBR Basel Simon Rüdisser Paul Erbel Anna Vulpetti Wolfgang Jahnke Anke Blechschmidt NIBR Cambridge, MA Xiaolu Zhang Jasna Fejzo MestreLab Research Chen Peng Manuel Perez Santiago Dominguez Carlos Cobas Université de Neuchâtel Claudio Dalvit 17 Improving NMR methods to support FBDD Andreas Lingel 2013/11/05 PSDI Lucerne